The Law Firm Of Weiss & Lurie Investigates HealthSpring, Inc.
Weiss & Lurie, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of HealthSpring, Inc. (NYSE: HS) arising from its proposed acquisition by Cigna Corporation (NYSE: CI) for $55.00 per share in cash, in a transaction valued at approximately $3.8 billion. The transaction is expected to close in the first half of 2012.
Weiss & Lurie is investigating whether HealthSpring’s Board acted in the best interests of its shareholders in approving the transaction and whether HealthSpring shareholders are receiving adequate consideration for their shares. HealthSpring’s existing management team, led by its Chairman and Chief Executive Officer, Herbert A. Fritch, will lead Cigna’s expansion into its Seniors and Medicare segments after the transaction closes.
If you own HealthSpring shares and would like more information about your rights as a shareholder or additional information concerning our investigation, please contact Michael A. Rogovin either by email at email@example.com or by telephone at (888) 593-4771.
Weiss & Lurie has litigated hundreds of stockholder class and derivative
actions for violations of corporate and fiduciary duties. We have
recovered over a billion dollars for defrauded institutions and
individuals and obtained important corporate governance in these cases.
If you have information or would like legal advice concerning possible
corporate wrongdoing (including insider trading, waste of corporate
assets, accounting fraud, or the improper dissemination of materially
misleading information), consumer fraud (including false advertising,
defective products, or other deceptive business practices), or
anti-trust violations, please email us at
or fill out the form on our website,
Advertising. Past results do not guarantee a similar outcome.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV